ong-term follow-up study after 'Treatment of lumbar canal stenosis with a combination of ultra-purified, allogenic, bone marrow-derived, mesenchymal stem cells (REC) and in situ-forming gel: a multicentre, prospective, double blind, randomised, controlled trial'
Not Applicable
Recruiting
- Conditions
- Combined lumbar canal stenosis
- Registration Number
- JPRN-jRCT1010230005
- Lead Sponsor
- Hideki Sudo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Willingness to provide written informed consent, fill in all necessary questionnaires, and return for follow-up.
Exclusion Criteria
Any other reason judged by an investigator or clinical trial doctor that renders the candidate unsuitable for this clinical trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method